Novavax (NVAX) Capital Leases (2012 - 2026)
Novavax (NVAX) reported Capital Leases of $1.72 million for Q2 2026, down 96.7% from $52.37 million a year earlier and down 9.9% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Capital Leases (2012 - 2026) Analysis & Trends
At the end of FY2025, Novavax posted Capital Leases of $2.09 million, down 96.1% from FY2024.
- Capital Leases has a five-year compound annual growth rate of -44.6% (FY2020 to FY2025).
- By year, Capital Leases came in at $53.73 million in FY2024 (-3.9%), $55.92 million in FY2023 (+79.0%) and $31.24 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Capital Leases since Q1 2014.
- Year over year, Capital Leases has now declined in each of the last seven quarters, with an average decline of 49.3% over the last eight quarters.
- The high point for year-over-year Capital Leases in five years was Q4 2023 (growth of 79.0%); the low point was Q2 2026 (a decline of 96.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.91 million (Q1 2026), $2.09 million (Q4 2025) and $2.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Novavax | 1.78 Bn | -1.22 Bn | 42.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.72 Mn |
| Mar 31, 2026 | 1.91 Mn |
| Dec 31, 2025 | 2.09 Mn |
| Sep 30, 2025 | 2.27 Mn |
| Jun 30, 2025 | 52.37 Mn |
| Mar 31, 2025 | 53.06 Mn |
| Dec 31, 2024 | 53.73 Mn |
| Sep 30, 2024 | 54.37 Mn |
| Jun 30, 2024 | 54.97 Mn |
| Mar 31, 2024 | 54.61 Mn |
| Dec 31, 2023 | 55.92 Mn |
| Sep 30, 2023 | 53.16 Mn |
| Jun 30, 2023 | 30.74 Mn |
| Mar 31, 2023 | 30.99 Mn |
| Dec 31, 2022 | 31.24 Mn |
| Sep 30, 2022 | 31.47 Mn |
| Jun 30, 2021 | 9.19 Mn |
| Mar 31, 2021 | 16.70 Mn |
| Dec 31, 2020 | 40.08 Mn |
| Sep 30, 2020 | 63.10 Mn |
API Access
Novavax Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();